A new drug called BPN14770 could protect against memory loss, nerve damage, and other Alzheimer's symptoms by fighting amyloid beta.

When researchers removed immune cells called microglia from mice with Alzheimer's, the disease's telltale plaques never formed.

The Alzheimer's drug donepezil can reverse the damage that alchohol exposure causes in the brains of adolescent rats. Could the same work for humans?

Researchers have discovered two genes that influence risk for early- and late-onset Alzheimer's disease, which could lead to new ways to fight the disease.

New research links chronic mid-life stress, though not trauma, with memory decline in women. That link did not appear for men.

An Alzheimer's blood test could also help scientists "more efficiently enroll participants in clinical trials, which will help us find treatments faster."

The new mouse model also holds promise for studying other neurological conditions such as Parkinson's disease, traumatic brain injury, and stroke.

75 percent of Alzheimer's disease patients are unlikely to benefit from a class of drugs that showed promise in animal studies, report researchers.

Intelligence and education may not protect you against Alzheimer's disease, but they could offer a protective "head start."

Doctors may one day diagnose Alzheimer's disease with a simple blood test. The new technology, called APEX, detects amyloid beta.